Tauriga Sciences Performance

The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Tauriga Sciences are completely uncorrelated.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tauriga Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tauriga Sciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow5348.00
Total Cashflows From Investing Activities-420 K
  

Tauriga Sciences Relative Risk vs. Return Landscape

If you would invest (100.00) in Tauriga Sciences on December 2, 2024 and sell it today you would earn a total of  100.00  from holding Tauriga Sciences or generate -100.0% return on investment over 90 days. Tauriga Sciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Tauriga, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketTAUG 0.00.10.20.30.40.50.60.70.8 -0.035-0.030-0.025-0.020-0.015-0.010-0.0050.0000.0050.010
       Risk  

Tauriga Sciences Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Tauriga Sciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Tauriga Sciences, and traders can use it to determine the average amount a Tauriga Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
TAUG
Based on monthly moving average Tauriga Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tauriga Sciences by adding Tauriga Sciences to a well-diversified portfolio.

Tauriga Sciences Fundamentals Growth

Tauriga OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Tauriga Sciences, and Tauriga Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tauriga OTC Stock performance.

Things to note about Tauriga Sciences performance evaluation

Checking the ongoing alerts about Tauriga Sciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Tauriga Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Tauriga Sciences is not yet fully synchronised with the market data
Tauriga Sciences has some characteristics of a very speculative penny stock
Tauriga Sciences has a very high chance of going through financial distress in the upcoming years
Tauriga Sciences currently holds 1.51 M in liabilities with Debt to Equity (D/E) ratio of 0.85, which is about average as compared to similar companies. Tauriga Sciences has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Tauriga Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Tauriga Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Tauriga Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Tauriga to invest in growth at high rates of return. When we think about Tauriga Sciences' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 285.32 K. Net Loss for the year was (3.63 M) with profit before overhead, payroll, taxes, and interest of 122.69 K.
Tauriga Sciences currently holds about 1.02 M in cash with (2.55 M) of positive cash flow from operations.
Evaluating Tauriga Sciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Tauriga Sciences' otc stock performance include:
  • Analyzing Tauriga Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tauriga Sciences' stock is overvalued or undervalued compared to its peers.
  • Examining Tauriga Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Tauriga Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tauriga Sciences' management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Tauriga Sciences' otc stock. These opinions can provide insight into Tauriga Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Tauriga Sciences' otc stock performance is not an exact science, and many factors can impact Tauriga Sciences' otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Tauriga OTC Stock

If you are still planning to invest in Tauriga Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tauriga Sciences' history and understand the potential risks before investing.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance